(ATS) ATS - Ratings and Ratios
Automation, Assembly, Testing, Software, Services
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 37.3% |
| Value at Risk 5%th | 56.7% |
| Relative Tail Risk | -7.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.16 |
| Alpha | -31.87 |
| CAGR/Max DD | -0.10 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.383 |
| Beta | 1.483 |
| Beta Downside | 1.102 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.76% |
| Mean DD | 27.88% |
| Median DD | 33.97% |
Description: ATS ATS November 07, 2025
ATS Corporation (NYSE: ATS) designs, builds, commissions and services automated manufacturing and assembly systems for a broad set of end-markets-including life sciences, transportation, consumer products, food & beverage, electronics, nuclear, packaging, warehousing and energy-while also providing pre- and post-automation consulting, contract manufacturing, and digital factory-floor solutions that capture real-time machine performance data.
Key metrics that have emerged in recent filings show FY 2023 revenue of roughly $1.3 billion with an operating margin near 7 percent, and a backlog growth rate of about 12 percent year-over-year, reflecting strong demand for automation amid persistent labor shortages and a global push to increase manufacturing productivity. The industrial automation sector is projected by the International Data Corporation (IDC) to expand at a 6 % compound annual growth rate through 2028, driven by rising adoption of Industry 4.0 technologies and tighter supply-chain resilience requirements-both tailwinds that directly benefit ATS’s diversified product and services portfolio.
For a deeper quantitative assessment, the ValueRay platform provides a granular breakdown of ATS’s valuation multiples and scenario analyses, which can help you gauge the company’s upside potential under different macro-economic assumptions.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-4.65m TTM) > 0 and > 6% of Revenue (6% = 161.5m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 5.71pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 36.92% (prev 34.49%; Δ 2.43pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 290.3m > Net Income -4.65m (YES >=105%, WARN >=100%) |
| Net Debt (1.48b) to EBITDA (200.6m) ratio: 7.37 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.92 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (98.0m) change vs 12m ago -0.41% (target <= -2.0% for YES) |
| Gross Margin 25.95% (prev 28.81%; Δ -2.86pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 59.17% (prev 64.33%; Δ -5.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.55 (EBITDA TTM 200.6m / Interest Expense TTM 104.4m) >= 6 (WARN >= 3) |
Altman Z'' 2.61
| (A) 0.21 = (Total Current Assets 2.07b - Total Current Liabilities 1.08b) / Total Assets 4.67b |
| (B) 0.16 = Retained Earnings (Balance) 729.3m / Total Assets 4.67b |
| (C) 0.01 = EBIT TTM 57.8m / Avg Total Assets 4.55b |
| (D) 0.59 = Book Value of Equity 1.72b / Total Liabilities 2.91b |
| Total Rating: 2.61 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 45.00
| 1. Piotroski 3.50pt |
| 2. FCF Yield 4.27% |
| 3. FCF Margin 8.19% |
| 4. Debt/Equity 0.99 |
| 5. Debt/Ebitda 7.37 |
| 6. ROIC - WACC (= -6.91)% |
| 7. RoE -0.27% |
| 8. Rev. Trend 40.62% |
| 9. EPS Trend -31.54% |
What is the price of ATS shares?
Over the past week, the price has changed by +0.99%, over one month by +1.44%, over three months by +1.03% and over the past year by -11.19%.
Is ATS a buy, sell or hold?
- Strong Buy: 1
- Buy: 5
- Hold: 2
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the ATS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33 | 19.9% |
| Analysts Target Price | 33 | 19.9% |
| ValueRay Target Price | 27.3 | -0.8% |
ATS Fundamental Data Overview December 12, 2025
P/E Forward = 17.094
P/S = 0.9939
P/B = 2.0938
Beta = 1.268
Revenue TTM = 2.69b CAD
EBIT TTM = 57.8m CAD
EBITDA TTM = 200.6m CAD
Long Term Debt = 1.39b CAD (from longTermDebt, last quarter)
Short Term Debt = 35.1m CAD (from shortTermDebt, last quarter)
Debt = 1.74b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.48b CAD (from netDebt column, last quarter)
Enterprise Value = 5.16b CAD (3.68b + Debt 1.74b - CCE 263.2m)
Interest Coverage Ratio = 0.55 (Ebit TTM 57.8m / Interest Expense TTM 104.4m)
FCF Yield = 4.27% (FCF TTM 220.5m / Enterprise Value 5.16b)
FCF Margin = 8.19% (FCF TTM 220.5m / Revenue TTM 2.69b)
Net Margin = -0.17% (Net Income TTM -4.65m / Revenue TTM 2.69b)
Gross Margin = 25.95% ((Revenue TTM 2.69b - Cost of Revenue TTM 1.99b) / Revenue TTM)
Gross Margin QoQ = 30.05% (prev 29.84%)
Tobins Q-Ratio = 1.11 (Enterprise Value 5.16b / Total Assets 4.67b)
Interest Expense / Debt = 1.40% (Interest Expense 24.4m / Debt 1.74b)
Taxrate = 33.82% (17.2m / 50.8m)
NOPAT = 38.2m (EBIT 57.8m * (1 - 33.82%))
Current Ratio = 1.92 (Total Current Assets 2.07b / Total Current Liabilities 1.08b)
Debt / Equity = 0.99 (Debt 1.74b / totalStockholderEquity, last quarter 1.75b)
Debt / EBITDA = 7.37 (Net Debt 1.48b / EBITDA 200.6m)
Debt / FCF = 6.71 (Net Debt 1.48b / FCF TTM 220.5m)
Total Stockholder Equity = 1.73b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.10% (Net Income -4.65m / Total Assets 4.67b)
RoE = -0.27% (Net Income TTM -4.65m / Total Stockholder Equity 1.73b)
RoCE = 1.85% (EBIT 57.8m / Capital Employed (Equity 1.73b + L.T.Debt 1.39b))
RoIC = 1.18% (NOPAT 38.2m / Invested Capital 3.23b)
WACC = 8.09% (E(3.68b)/V(5.43b) * Re(11.48%) + D(1.74b)/V(5.43b) * Rd(1.40%) * (1-Tc(0.34)))
Discount Rate = 11.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.76%
[DCF Debug] Terminal Value 56.71% ; FCFE base≈220.5m ; Y1≈144.8m ; Y5≈66.2m
Fair Price DCF = 8.50 (DCF Value 823.6m / Shares Outstanding 96.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -31.54 | EPS CAGR: 14.56% | SUE: 0.08 | # QB: 0
Revenue Correlation: 40.62 | Revenue CAGR: 7.95% | SUE: N/A | # QB: 0
EPS current Year (2026-03-31): EPS=1.27 | Chg30d=-0.068 | Revisions Net=-3 | Growth EPS=+19.2% | Growth Revenue=+16.0%
EPS next Year (2027-03-31): EPS=1.60 | Chg30d=-0.084 | Revisions Net=-2 | Growth EPS=+25.9% | Growth Revenue=+5.1%
Additional Sources for ATS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle